Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Eyepoint To Contact Him Directly To Discuss Their Options
New York, New York–(Newsfile Corp. – November 24, 2022) – Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against EyePoint Pharmaceuticals (“Eyepoint” or the “Company”) (NASDAQ : EYPT). If you suffered losses exceeding $50,000 investing in Eyepoint stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330. 13 ( . You may also click here for additional information: www.faruqilaw.com/EYPT.